EUR vs Nigeria: Hepatitis B surface antigen (HBsAg) prevalence
EUR
0.1%
in 2024
Nigeria
2.7%
in 2024
EUR rank
10th
Nigeria rank
8th
Hepatitis B surface antigen (HBsAg) prevalence over time
- EUR
- Nigeria
How they compare
Nigeria currently reports 2.7% against 0.1% in EUR, a difference of 2.6%.
That makes Nigeria's figure about 27.0 times EUR's.
Across all 10 years both countries report, Nigeria has been ahead every year.
EUR ranks 10th and Nigeria ranks 8th of 13 groups.
Nigeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | EUR | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 3.7% | 3.6% | Nigeria |
| 2020s | 0.1% | 3.1% | 3.0% | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, EUR or Nigeria?
- Nigeria, at 2.7% against 0.1% in EUR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between EUR and Nigeria?
- 2.6%, with Nigeria ahead.
- How many years of comparable data are there for EUR and Nigeria?
- 10 years are reported by both, from 2015 to 2024.
- How do EUR and Nigeria rank globally for hepatitis b surface antigen (hbsag) prevalence?
- EUR ranks 10th and Nigeria ranks 8th of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.